Further statistical analysis details
Comparison of subjects who achieved target A1C ≤6.0% at both 24 and 36 gestational weeks (GWs) was made with logistic regression, using the same factors and covariates as for the primary endpoint. Superiority was tested. Analysis of fasting plasma glucose (FPG) at 24 and 36 GWs was made separately using a normal linear regression model with treatment, country, and pregnancy status at randomization as factors, and FPG at randomization and the FPG at randomization by pregnancy status at randomization interaction as covariates. Superiority was tested for FPG. Analysis of the 8-point selfmonitored plasma glucose (SMPG) profiles at 24 GWs was made using a linear mixed model where time point (i.e., time of measurement during the day) was the repeated measurement within a subject. The fixed factors in the model were treatment, time point, country, time point by treatment interaction, and pregnancy status at randomization. An unstructured covariance matrix was applied. The individual profiles were tested to see if they were parallel (considered to exist if the interaction between time and treatment was non-significant), in which case the model was reduced by omitting the interaction term. . Analysis of 8-point SMPG at 36 GWs was made using the same model, except that a compound symmetry covariance matrix was applied (due to lack of convergence when using an unstructured covariance matrix). 
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